| P2093 | author name string | David Feifel | |
| | Kai Macdonald | |
| P2860 | cites work | Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity | Q22255499 |
| | Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia | Q84759806 |
| | Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans | Q22255501 |
| | Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala | Q22299356 |
| | Structure and expression of a human oxytocin receptor | Q24336185 |
| | The human amygdala is necessary for developing and expressing normal interpersonal trust | Q24601049 |
| | Adult attachment predicts maternal brain and oxytocin response to infant cues | Q24619346 |
| | From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? | Q24648383 |
| | Molecular mechanisms of antidiuretic effect of oxytocin | Q24649233 |
| | Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans | Q24656041 |
| | Emergent synchronous bursting of oxytocin neuronal network | Q27336767 |
| | Oxytocin responsivity in mothers of infants: a preliminary study of relationships with blood pressure during laboratory stress and normal ambulatory activity | Q28141014 |
| | Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight | Q28143505 |
| | The oxytocin receptor system: structure, function, and regulation | Q28207331 |
| | Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review | Q28215767 |
| | Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges | Q28215773 |
| | Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies | Q28215775 |
| | A neurobiological basis of social attachment | Q28239295 |
| | Oxytocin increases trust in humans | Q28254266 |
| | Social defeat: risk factor for schizophrenia? | Q28264772 |
| | Oxytocin is associated with human trustworthiness | Q28267939 |
| | Central vasopressin and oxytocin release: regulation of complex social behaviours | Q28288549 |
| | Oxytocin attenuates the cocaine-induced exploratory hyperactivity in mice | Q28334562 |
| | Prenatal stress generates deficits in rat social behavior: Reversal by oxytocin | Q28577893 |
| | CNS region-specific oxytocin receptor expression: importance in regulation of anxiety and sex behavior | Q28578718 |
| | The expression of neuropeptide-induced excessive grooming behavior in dopamine D1 and D2 receptor-deficient mice | Q28584808 |
| | Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse | Q28727394 |
| | Structural pathology underlying neuroendocrine dysfunction in schizophrenia | Q30409351 |
| | The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating | Q30427738 |
| | The environment and susceptibility to schizophrenia | Q30459929 |
| | Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia | Q30464312 |
| | Clozapine and PD149163 elevate prepulse inhibition in Brown Norway rats | Q30468932 |
| | A review of emotion deficits in schizophrenia | Q30473420 |
| | Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits | Q30492008 |
| | A hormone-activated central pattern generator for courtship | Q30494213 |
| | Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans | Q30494974 |
| | Evidence for a role of oxytocin receptors in the long-term establishment of dominance hierarchies | Q30504499 |
| | Reduced anterior hippocampal formation volume in hyponatremic schizophrenic patients | Q31108960 |
| | Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. | Q31997655 |
| | Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry | Q33506130 |
| | Protocol for an experimental investigation of the roles of oxytocin and social support in neuroendocrine, cardiovascular, and subjective responses to stress across age and gender | Q33520115 |
| | Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia | Q33603714 |
| | Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity | Q33651662 |
| | The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior | Q33761364 |
| | Mesotocin and nonapeptide receptors promote estrildid flocking behavior | Q33821150 |
| | Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. | Q33848243 |
| | Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors | Q33948059 |
| | Promise and pitfalls of animal models of schizophrenia | Q33956579 |
| | Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia | Q33957624 |
| | Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse | Q33989258 |
| | Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients | Q34023024 |
| | Natural variations in maternal and paternal care are associated with systematic changes in oxytocin following parent-infant contact | Q34098554 |
| | Sniffing neuropeptides: a transnasal approach to the human brain | Q34126887 |
| | Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials | Q34160338 |
| | Oxytocin selectively gates fear responses through distinct outputs from the central amygdala | Q34196729 |
| | The Steroid/Peptide Theory of Social Bonds: integrating testosterone and peptide responses for classifying social behavioral contexts | Q34197062 |
| | Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis | Q34213209 |
| | Peripheral oxytocin is associated with reduced symptom severity in schizophrenia | Q34311629 |
| | Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication | Q34374925 |
| | Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. | Q34384624 |
| | Dendritic peptide release and peptide-dependent behaviours | Q34486938 |
| | A meta-analysis of the efficacy of second-generation antipsychotics | Q34534321 |
| | Oxytocin attenuates amygdala responses to emotional faces regardless of valence | Q34580947 |
| | Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin. | Q34590214 |
| | Association of the oxytocin receptor (OXTR) gene polymorphisms with autism spectrum disorder (ASD) in the Japanese population. | Q34616103 |
| | Social effects of oxytocin in humans: context and person matter | Q34630520 |
| | The acute effects of intranasal oxytocin administration on endocrine and sexual function in males. | Q34765587 |
| | Oxytocin shapes the neural circuitry of trust and trust adaptation in humans | Q34781060 |
| | Antidiuretic effects of oxytocin, morphine and pethidine in pregnancy and labour | Q79442202 |
| | Implicit trustworthiness decisions: automatic coding of face properties in the human amygdala | Q80831010 |
| | Oxytocin revisited: It is also a cardiovascular hormone | Q84088933 |
| | Variants in the oxytocin gene and risk for schizophrenia | Q84402564 |
| | Oxytocin-messages via the cerebrospinal fluid: behavioral effects; a review | Q37759344 |
| | Gender-related endocrinological dysfunction and mental disorders. | Q37760007 |
| | Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. | Q37765942 |
| | The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis | Q37771567 |
| | Central control of penile erection: a re-visitation of the role of oxytocin and its interaction with dopamine and glutamic acid in male rats | Q37807128 |
| | Antipsychotic occupancy of dopamine receptors in schizophrenia | Q37818511 |
| | A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. | Q37856511 |
| | Sexual dimorphism in schizophrenia: is there a need for gender-based protocols? | Q37896624 |
| | Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine | Q37919724 |
| | Does dopamine play a role in schizophrenia? | Q39177114 |
| | From maps to mechanisms through neuroimaging of schizophrenia | Q39818506 |
| | The environment and schizophrenia | Q39958490 |
| | An historical review of the use of oxytocin prior to delivery | Q40032772 |
| | Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground | Q40424300 |
| | Neurohypophysial peptides in cerebrospinal fluid: an update | Q40846755 |
| | Breastfeeding: physiological, endocrine and behavioural adaptations caused by oxytocin and local neurogenic activity in the nipple and mammary gland | Q41127783 |
| | Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity | Q41608731 |
| | The acoustic startle response in rats--circuits mediating evocation, inhibition and potentiation | Q41706989 |
| | Prepulse startle deficit in the Brown Norway rat: a potential genetic model | Q41738580 |
| | Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex | Q42493116 |
| | Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses | Q43093674 |
| | Oxytocin is neuroprotective against oxygen-glucose deprivation and reoxygenation in immature hippocampal cultures | Q43095354 |
| | Schizophrenia severity and clozapine treatment outcome association with oxytocinergic genes | Q43144926 |
| | Dopamine-oxytocin interactions in penile erection | Q43175428 |
| | Phencyclidine-induced psychosis | Q43637366 |
| | A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia | Q43692964 |
| | Plasma levels of oxytocin during the menstrual cycle, pregnancy and following treatment with HMG. | Q43899652 |
| | Female Oxytocin-Deficient Mice Display Enhanced Anxiety-Related Behavior | Q44440486 |
| | Prolactin and oxytocin interaction in the paraventricular and supraoptic nuclei: effects on oxytocin mRNA and nitric oxide synthase | Q44465665 |
| | Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus. | Q44496769 |
| | Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles | Q44624436 |
| | Effect of a single dose of des-glycinamide-[Arg8]vasopressin or oxytocin on cognitive processes in young healthy subjects | Q44758720 |
| | Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. | Q44804073 |
| | Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. | Q44814703 |
| | Variations in nucleus accumbens dopamine associated with individual differences in maternal behavior in the rat. | Q44872451 |
| | Effects of oxytocin in normal man during low and high sodium diets | Q44924061 |
| | Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree | Q45032796 |
| | Neuropeptide regulation of social behavior in a monogamous cichlid fish | Q45094544 |
| | Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. | Q45175683 |
| | Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women | Q45233376 |
| | Localization of oxytocin binding sites in the human brainstem and upper spinal cord: an autoradiographic study | Q45304416 |
| | Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin | Q45765486 |
| | Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement | Q46048577 |
| | Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects | Q46287289 |
| | Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin | Q46411318 |
| | Oxytocin and neurophysin in plasma and CSF during suckling in the guinea-pig | Q46442163 |
| | Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating | Q46595907 |
| | Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact | Q46620706 |
| | Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice | Q46785915 |
| | Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology | Q34783101 |
| | Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis. | Q34898825 |
| | Effects of intranasal oxytocin on emotional face processing in women | Q34994119 |
| | Molecular approaches to aggregation behavior and social attachment | Q35027422 |
| | Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia | Q35115758 |
| | Developmental consequences of oxytocin | Q35211185 |
| | Oxytocin — A neuropeptide for affiliation: Evidence from behavioral, receptor autoradiographic, and comparative studies | Q35229289 |
| | Oxytocin receptors in the central nervous system. Distribution, development, and species differences | Q35230045 |
| | A dopaminergic deficit hypothesis of schizophrenia: the path to discovery | Q35236663 |
| | Animal behavior models of the mechanisms underlying antipsychotic atypicality | Q35595230 |
| | Emotion recognition and oxytocin in patients with schizophrenia | Q35647312 |
| | Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in men. | Q35653107 |
| | Is nose-to-brain transport of drugs in man a reality? | Q35673938 |
| | Cortical cholinergic transmission and cortical information processing in schizophrenia | Q36124290 |
| | Structure and comparison of the oxytocin and vasopressin genes from rat | Q36266006 |
| | How do we know the minds of others? Domain-specificity, simulation, and enactive social cognition | Q36409312 |
| | Oxytocin stimulates adult neurogenesis even under conditions of stress and elevated glucocorticoids | Q36588279 |
| | Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study | Q36784855 |
| | Stimuli and consequences of dendritic release of oxytocin within the brain | Q36979768 |
| | Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia | Q37075939 |
| | Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia | Q37120692 |
| | Novel aspects of glutamatergic signalling in the neuroendocrine system | Q37207345 |
| | Steroidal/neuropeptide interactions in hypothalamus and amygdala related to social anxiety. | Q37227027 |
| | Oxytocin, vasopressin and sociality | Q37227032 |
| | Oxytocin, vasopressin, and the neurogenetics of sociality | Q37319197 |
| | Dopaminergic-neuropeptide interactions in the social brain | Q37351370 |
| | The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial | Q37394738 |
| | Social cognition and interaction training (SCIT) for outpatients with schizophrenia: a preliminary study | Q37409812 |
| | Oxytocin and the development of parenting in humans | Q37618794 |
| | The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans | Q37667058 |
| | Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice | Q46842190 |
| | Dynamic changes in oxytocin receptor expression and activation at parturition in the rat brain | Q48106830 |
| | Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia | Q48154990 |
| | Dopamine neurotransmission in the nucleus accumbens may be involved in oxytocin-enhanced grooming behavior of the rat. | Q48350508 |
| | Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients | Q48362857 |
| | Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia. | Q48381391 |
| | Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia | Q48381678 |
| | Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade | Q48382169 |
| | The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects? | Q48398177 |
| | Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics | Q48417307 |
| | Water intoxication and hyponatremic encephalopathy from the use of an oxytocin nasal spray. A case report | Q48514911 |
| | Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics | Q48522635 |
| | Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study | Q48675360 |
| | Oxytocin in the medial amygdala is essential for social recognition in the mouse. | Q48764530 |
| | Effects of oxytocin, des-glycinamide-oxytocin and anti-oxytocin serum on the α-MPT-induced disappearance of catecholamines in the rat brain | Q48795542 |
| | Vasopressin and oxytocin release in the brain--a synaptic event | Q48860592 |
| | The influence of depressive symptomatology and perceived stress on plasma and salivary oxytocin before, during and after a support enhancement intervention | Q48884097 |
| | Relationships among estrogen receptor, oxytocin and vasopressin gene expression and social interaction in male mice | Q49057898 |
| | Maternal and paternal plasma, salivary, and urinary oxytocin and parent-infant synchrony: considering stress and affiliation components of human bonding | Q49162376 |
| | Association between the oxytocin receptor gene and amygdalar volume in healthy adults. | Q50302270 |
| | Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. | Q50312848 |
| | Interaction of 5-HTTLPR and a variation on the oxytocin receptor gene influences negative emotionality. | Q50652337 |
| | Effects of long-term treatment with oxytocin in chronic constipation; a double blind, placebo-controlled pilot trial. | Q50956590 |
| | Sharing secrets: oxytocin and trust in schizophrenia. | Q51887808 |
| | Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication. | Q52028971 |
| | Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls. | Q52207888 |
| | Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. | Q52212982 |
| | The effect of oral contraceptive pills on levels of oxytocin in plasma and on cognitive functions. | Q52254576 |
| | Experimental peripheral administration of oxytocin elevates a suite of cooperative behaviours in a wild social mammal | Q55174635 |
| | Schizophrenia | Q55868331 |
| | Oxytocin as a moderator of hypnotizability | Q57244593 |
| | Oxytocin Modulates Amygdala, Insula, and Inferior Frontal Gyrus Responses to Infant Crying: A Randomized Controlled Trial | Q57823304 |
| | Previous maternal experience potentiates the effect of parturition on oxytocin receptor mRNA expression in the paraventricular nucleus | Q59925983 |
| | Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia | Q60608697 |
| | Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats | Q67527076 |
| | Pattern of oxytocin concentrations in the plasma and cerebrospinal fluid of lactating rhesus monkeys (Macaca mulatta): evidence for functionally independent oxytocinergic pathways in primates | Q68586064 |
| | Psychotropic properties of oxytocin | Q69599024 |
| | Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha | Q69924386 |
| | Circulating immunoreactive oxytocin during the human menstrual cycle comes from the pituitary and is estradiol dependent | Q69948866 |
| | Hormones in the treatment of psychoses | Q70508353 |
| | Cerebrospinal fluid neurophysins in affective illness and in schizophrenia | Q70644691 |
| | A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans | Q71042707 |
| | [Psychotropic properties of oxytocin] | Q71338247 |
| | Immunohistochemistry of vasopressin, oxytocin and neurophysin in the hypothalamus and extrahypothalamic regions of the human and primate brain | Q71548759 |
| | Penetration of neurohypophyseal hormones from plasma into cerebrospinal fluid (CSF): half-times of disappearance of these neuropeptides from CSF | Q71680670 |
| | Hyponatraemia and non-electrolyte solutions in labouring primigravida | Q72015301 |
| | Serum profiles of oxytocin during oral contraceptive treatment | Q72758570 |
| P433 | issue | 3 | |
| P921 | main subject | schizophrenia | Q41112 |
| | oxytocin | Q169960 |
| P304 | page(s) | 130-146 | |
| P577 | publication date | 2011-12-19 | |
| P1433 | published in | Acta Neuropsychiatrica | Q4676734 |
| P1476 | title | Oxytocin in schizophrenia: a review of evidence for its therapeutic effects | |
| P478 | volume | 24 | |